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Abstract
Peripheral vascular malformations (PVMs) represent a wide spectrum of vascular abnormalities
occurring due to anomalous connections between arteries, veins, capillaries, and lymphatic
channels at the microscopic level, in different combinations. They are rare and challenging to
treat. Different operators may have different approaches based on their experience and
expertise. Sclerotherapy either alone or in combination with embolization has been used as an
independent method for the treatment of PVMs.
Purpose
The aim of this study is to assess the safety and efficacy of sclerotherapy and embolization,
with or without surgery, for the treatment of peripheral vascular malformations, based on our
approach.
Materials and methods
A retrospective review of all patients with PVMs treated in our interventional radiology
department from 2011 to 2017 was carried out. Medical records, imaging, and follow-up notes
were reviewed to evaluate the response to treatment and post-procedure complications.
Results
Thirty-four sessions were performed in 15 patients (eight male, seven female) with PVMs. Low-
flow lesions were identified in 10, intermediate flow in one, and high flow in four patients.
Sodium tetradecyl sulfate (STS) was used as the sclerotherapeutic agent in 10 (66.67%), glue
with lipoidal in three (20.0%), and bleomycin in one patient (6.67%). Coils with PVA and a
covered stent were used in one and a combination of coil, PVA, and gel foam was used in one
patient. A marked response was seen in 11 and a partial response in four patients. One patient
developed foot gangrene. Stent thrombosis was noted in one patient with no clinical
consequences. Recurrence was seen in two patients, who were lost to follow up.
Conclusion
PVMs are complex lesions. Sclerotherapy with or without embolization is a safe and effective
treatment modality, with clinical response approaching 100%.
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Introduction
Peripheral vascular malformations (PVMs) represent a wide spectrum of vascular abnormalities
occurring due to anomalous connections between arteries, veins, capillaries, and lymphatic
channels at the microscopic level, in different combinations [1]. These lesions are characterized
as low-, intermediate-, and high-flow lesions depending upon the flow velocity. Symptoms such
as pain, swelling, functional disabilities, and cosmetic deformity can lead to significant
morbidity.
Sclerotherapy either alone or in combination with embolization has been used as an
independent method for the treatment of PVMs. It can also be used as an adjunct to surgery [2-
3]. Various agents are used in sclerotherapy and the embolization of PVMs, including sodium
tetradecyl sulfate (STS), bleomycin, ethanol, ethanolamine oleate, glue, covered stents, coils,
polyvinyl alcohol particles (PVA), and gel foam. The selection of sclerotherapeutic and
embolizing agents vary depending on the location and characteristics of
vascular malformations and radiologist preference. As PVMs are rare in occurrence, challenging
to treat, and there is significant variation in the choice of sclerotherapeutic and embolizing
agents among different operators depending on their personal preference and experience, we
wanted to see the safety and efficacy of our initial experience in treating PVMs.
Materials And Methods
In this study, we carried out a retrospective review of all peripheral vascular malformations
(PVMs) treated in our vascular interventional radiology (VIR) department from 2011 to 2017.
Informed consent was obtained from all patients. The diagnosis of PVMs was made on the basis
of physical examinations and imaging. Imaging modalities included ultrasound (U/S) and
magnetic resonance imaging (MRI) in all patients. In high- and intermediate-flow lesions,
angiography was also performed. U/S imaging was done on Toshiba Xario 100 (Canon Medical
Systems Corporation, Tochigi Prefecture, Japan) using 5 MHz and 7.5 MHz high-frequency
probes with color Doppler. Magnetic resonance imaging (MRI) was done on Toshiba Excelart
Vantage (ATLAS) 1.5 Tesla (Canon Medical Systems Corporation, Tochigi Prefecture, Japan).
The MRI protocol included T1-, T2-weighted images with and without fat saturation and post-
contrast T1-weighted images with fat saturation in the axial, coronal, and sagittal planes.
Lesions were characterized as high, intermediate, and low flow depending on their flow pattern
and velocities. Lesions showing only monophasic venous flow were labeled as low flow and
those with a predominant arterial flow pattern were labeled as high flow. PVMs with
predominant venous low but also having arterial flow were taken as intermediate flow.
Sclerotherapy and embolization were performed under real-time U/S and fluoroscopic guidance
using STS (3% sodium tetradecyl sulphate, Setrol, Samrath Life Sciences, Mumbai, India), glue
(Glubran, GEM S.R.L, Viareggio, Italy) with lipoidol (lipoidol ultra-fluid 480 mg/ml, Guerbet,
Istanbul), bleomycin (Bleomycin 15mg, Fresenius Kabi, USA), covered stent (wall graft, Boston
Scientific, USA), gelfoam (Equispon, Eguimedical BV, The Netherlands), coils (2D Helical-35,
Boston Scientific, Cork, Ireland), and PVA particles (Contour, Boston Scientific, USA).
Sclerotherapeutic and embolizing agents were selected according to the location and
characteristics of PVMs.
STS was used for low and intermediate-flow lesions and high-flow lesions were embolized
using a covered stent, coils, PVA, gel foam, glue, and bleomycin in various combinations, as
shown in Table 1.
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Patient
Age
(years)
Gender
Location of
PVMs
Presenting symptoms Flow
No. of
sessions
Sclerosing
agent
Clinical
response
Outcome Complications
Duration
of
follow-
up
1. 10 Male
Bilateral
parapharyngeal
spaces
Progressive dyspnea and
dysphagia. Dyspnea aggravated
during sleep, resulting in an inability
to go into deep sleep.
Low 3 STS  
Resolution of
dyspnea
Marked
response
None  
19
months  
2. 16 Female
Planter and
dorsal aspect of
right foot
K/c right foot vascular
malformation, pain in right foot
Low  1  STS
Resolution of
pain
Marked
response
Distal foot
gangrene
16
months  
3. 37
Female
 
Right
parapharyngeal
space extending
into larynx
Painless swelling in the neck on
the right side for last 2 yrs that is
progressively increasing in size
Low  2  STS
50%
reduction in
swelling
Partial
response  
None  
16
months  
4. 23
Female
 
Posterior aspect
of left calf  
Pain in the left leg for 10 yrs that
was increasing in severity for the
last 2 yrs
Low  1  STS
Resolution of
pain  
Marked
response  
None  
14
months  
5. 31  Male  
Lateral aspect of
right elbow  
Severe pain in right arm  Low  3 STS
Resolution of
pain.
Marked
response  
None  4 yrs  
6. 35  Male  Left eyelid  
Ptosis of left eyelid, difficulty in
opening the eye, no visual
impairment
High 1
Bleomycin
 
Significant
resolution.
He was able
to open his
eye.
Partial
response  
None  
Lost to
F/U.  
7. 32 Male  Right ankle  
Pain in right ankle extending into
calf  
Low  7
Glue with
lipiodol  
50%
reduction in
size on post-
procedure
MRI
Partial
response  
None  5 yrs  
8. 18
Female
 
Right lower limb
Multiple lesions in right lower limb,
pain in right lower limb  
Low  2 STS
Resolution of
pain  
Marked initial
response,
recurrence
on 2-yr F/U  
 
None  3 yrs  
9. 18  
Female
 
Left arm  Left arm pain and swelling  High  2  
Glue with
lipiodol,
wall-graft
stent.  
Resolution of
pain and
swelling
Marked
response  
None  4 yrs  
10. 22  
Female
 
Right distal thigh
 
Pain and swelling in right distal
thigh since childhood increasing for
2-3 yrs
Low  3 STS
Resolution of
pain  
Partial
response,
recurrence
on 3yr F/U
None  4 yrs  
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11. 20  Male  Face  Bleeding from gums  High  1
Coils with
PVA and
gel foam  
Cessation of
bleeding
Marked
response  
None  4 yrs  
12. 17  Male  Right arm  
Pain on compression, swelling
increasing in size  
Low  2 STS
Resolution of
pain and
swelling
Marked
response  
None  3 yrs  
13. 18
Female
 
Face  
Extensive vascular malformation on
face  
High  2
Coils with
PVA  
Complete
resolution
Marked
response  
None  4 yrs  
14. 22  Male Left forearm  
Pain and swelling increasing in size
for last 3 months  
Intermediate
 
1
STS, Glue
with
lipiodol  
Resolution of
pain and
swelling
Marked
response  
None  
13
months  
15 22 Male Neck
Diffuse neck swelling with difficulty
in breathing and swallowing
low 2 STS
60% to 70%
resolution of
swelling and
symptoms
Marked
response
None
5
months
TABLE 1: Patients' information according to region involved, presenting symptoms,
flow characteristics, number of sessions, agents used, response, and follow-up.
After localizing the lesion under U/S, cannulation with a needle (20G, 22G, 25G BD spinal
needle, Becton Dickinson SA, Spain) was done and contrast (Iomeprol, Braccos PA, Milano,
Italy) was injected to delineate the lesion on fluoroscopy. A percutaneous injection of
sclerotherapeutic and embolizing agents was done using U/S and fluoroscopic guidance. The
outflow veins were occluded or compressed using a tourniquet during the injection, wherever
possible. STS foam was created with STS mixed with air and contrast, each in equal amounts.
People have mixed STS with lipiodol but because of the financial constraints of many patients
in Pakistan, we are using non-ionic contrast instead of lipiodol. Glue was usually injected in
combination with lipiodol in a 1:1 ratio. The amount of glue and lipiodol varied according to
the lesion size and response. The injection was stopped when thrombosis of vascular channels
was seen on U/S and a loss of flow was identified on angiography. However, angiography was
done only in selected cases in intermediate- and high-flow lesions.
Technical success is defined as the optimal injection of sclerosant or the exclusion of lesion by
embolization as demonstrated by angiography or U/S. Clinical success is assessed by a reduction
in pain and an improvement in swelling and function. Clinical response is categorized as
marked response, partial response, and no response. Patients showing complete resolution of
symptoms were labeled as having marked response, those showing a reduction in symptoms as
partial response, and as no response when no change in symptoms was noted. Clinical
outcomes were determined by reviewing all the pre- and post-procedure imaging and follow-up
notes in the interventional radiology clinic. MRI was not routinely done in the follow-up of all
patients. Follow-up of all patients included clinical evaluation, physical examination, and
grayscale and color Doppler U/S.
Results
Thirty-four sessions were performed in 15 patients (eight male, seven female) with PVMs. The
mean age of patients was 22.7 years (range 10-37 years). Nine patients had pain (60.0%), six
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had a swelling (40.0%), one had ptosis (6.67%), two had dyspnea affecting sleep significantly
(13.34%), and one patient presented with life-threatening oral hemorrhage (6.67%). One
patient with low-flow vascular malformation in a lower limb had prior surgery with no
significant response. The average follow-up duration was 2.71 years (0.4-5 years). The
distribution of vascular malformation according to flow characteristics and region
of involvement is shown in Table 2.
Region involved
PVMs flow characteristics
Total
High flow Intermediate flow Low flow
Upper limb 1 1 2 4
Lower limb 0 0 5 5
Head and neck 3 0 3 6
Total 4 1 10 15
TABLE 2: Distribution of vascular malformations according to flow characteristics
and region of involvement
STS alone was used as the sclerotherapeutic agent in nine patients. Glue with lipiodol was used
in three patients. Out of these, one had covered stent placement and another had STS
injection. Bleomycin was used in one patient. Coils along with PVA particles were used in one
patient and a combination of coils, PVA, and gel foam was used in one patient with a high-flow
vascular malformation. A 100% technical success rate was achieved. Clinical success was 100%.
A marked clinical response was seen in 11 out of 15 patients (73.34%) with a resolution of
symptoms. Four out of 15 (26.67%) patients showed partial response and no patients were
noted in the no response category. One patient developed complication in the form of
gangrene in the toes and the second to fifth toes were amputated. Stent thrombosis was noted
in one patient without any clinical consequences or functional restriction. Therefore, we did
not go for further intervention for the restoration of stent patency. A recurrence was seen in
three patients who were lost to follow-up and visited us two and three years later.
Discussion
PVMs are rare and challenging lesions to treat with an estimated prevalence of 1.5 % in the
population [4]. A multidisciplinary approach, including an interventional radiologist, surgeon,
dermatologist, hematologist, pathologist, and oncologist, is critical in the diagnosis and
management of PVMs. Many times, surgical excision because of the proximity of vital
structures is not possible for the treatment of PVMs. Therefore, it is of immense importance
that the interventional radiologist is aware of the available treatment techniques and is skilled
in their implementation, keeping in view the associated benefits, complications, and outcomes.
In our study, we have performed sclerotherapy in two patients having vascular malformations
in the foot. One patient had a vascular malformation in both the planter and dorsal aspects of
the foot. Surgery was attempted but complete excision was not achieved. At three different
sites, STS foam admixed with glue and air was injected and a compression bandage was
applied. The patient developed distal foot gangrene and all toes were amputated. There was
a complete response with a resolution of pain and lesion on follow-up. In our opinion, this
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complication developed due to the tight compression bandage applied after the procedure and
the inability of duty doctors to appreciate an ischemic event in a timely manner. Moreover, this
patient also had a previous surgery of the foot that led to compromised vascular supply and
may have contributed to the development of gangrene. Therefore, care should be taken in
applying a compression bandage after sclerotherapy so that a venous outflow obstruction
resulting in the swelling of the limb or vascular compromise should not occur. Close patient
observation is necessary following the sclerotherapy of lesions involving limbs distally. Weiss et
al. reported that 30 mmHg support stockings worn for three weeks after sclerotherapy is not
only effective immediately after injection but also yield better results in the long term [5]. The
two other patients had a vascular malformation in the lower limb, one in the foot and the other
in the thigh. Sclerotherapy was done using STS in both patients. There was a complete clinical
response with no complication; however, they were lost to follow-up and later presented with a
recurrence of the disease and symptoms. This signifies the fact that long-term follow-up is
mandatory in PVMs for achieving marked clinical success. Patients who are lost to follow-up
may present with a recurrence of symptoms.
An 18-year-old female presented with pain in the left upper limb. Imaging revealed multiple,
tiny outpouchings arising from the brachial artery, which were excluded by placing a covered
stent (Figure 1).
FIGURE 1: CT scan with contrast (A) and digital subtraction
angiogram (B) of an 18-year-old patient showing multiple tiny
outpouchings (Arrows) arising from the brachial artery
Post-stenting angiogram revealed a few vascular channels filling in the venous phase (Figure
2). 
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FIGURE 2: Post-stenting angiogram showing a few vascular
channels (Arrow) filling in the venous phase
These were embolized with a percutaneous injection of glue, resulting in the complete
exclusion of the lesion (Figure 3). 
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FIGURE 3: Post-procedure angiogram (A) and Doppler
ultrasound (B) showing the complete exclusion of the lesion
At the three months follow-up, the occlusion of the stent was noted with the development of
collaterals from the profunda brachii artery, re-forming the brachial artery with a good distal
flow. There was no pain or limitation of movement, so no further intervention was done and
the patient has been asymptomatic for the last three years. We did not include it as a
complication. Out of 15 patients, nine have vascular malformations in the limbs and only one
patient developed complications in the form of gangrene. Ali S et al. reported a 20%
complication rate in the treatment of venous malformations treated with percutaneous
sclerotherapy [6]. Our experience shows a low risk of complication (6.67 %) in patients with
PVMs. It is significantly lower as compared to the previous studies [7-9].
Castren E et al. [10] published a series of 75 patients who underwent sclerotherapy for vascular
malformations (VM) in the region of the head and neck with a 17.3% complication rate. In our
study, we treated six patients with vascular malformations in the region of the head and neck
with a significant improvement in pain, swelling, and function without any complication. One
patient had extensive vascular malformation involving the carotid, pharyngeal, and
parapharyngeal spaces, causing a significant compression of the airway, resulting in an
inability to sleep. To avoid the compression of the airway from inflammation and edema, a
tracheostomy was done before the sclerotherapy. His follow-up MRI after two sessions of
sclerotherapy revealed intermediate and low signals appearing in a previously noted
homogenously T2W hyperintense lesion. A concomitant laryngoscope examination revealed
a decrease in the size and pressure effect of VM over the airway. A marked clinical response was
noted in this patient with significant improvement in his symptoms. In another patient, a
high-flow vascular malformation was noted in the upper eyelid, causing marked ptosis of
the eyelid. Sclerotherapy with bleomycin was performed and partial response was noted after
the procedure. This patient didn’t turn up for follow-up.
A 22-year-old male presented with a huge neck swelling, which caused episodic dyspnea. A
computed tomography (CT) scan revealed significant pressure over the airway. Two sessions of
sclerotherapy were performed after endotracheal intubation. A significant reduction in
swelling with a resolution of dyspnea was noted in the five-month follow-up (Figure 4).
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FIGURE 4: A. Patient presented with a diffuse neck swelling. B.
Marked reduction noted in the neck swelling after
sclerotherapy with STS
STS: sodium tetradecyl sulfate
None of our patients with a vascular malformation in the head and neck developed
complications after the procedure.
In the literature, there is a difference in the choice of sclerotherapeutic agents among different
authors. We have used STS as the sclerotherapeutic agent in most of our procedures, as it is one
of the most-effective and safest agents used for sclerotherapy, with a success rate comparable
to ethanol [11]. However, it can cause various adverse reactions, such as sloughing and necrosis
of tissues, skin discoloration, and allergic reactions. The incidence of allergic reactions after
STS injections ranges from 0.15% to 0.30%. In our study, only one patient developed an allergic
response to the test dose of STS. This patient had seven sessions of sclerotherapy. Bleomycin
was also given but there was no clinical response. In this patient, we used glue admixed with
lipiodol for sclerotherapy. He showed a marked clinical response. Allergic and anaphylactic
responses were also reported with the use of STS in previous studies. In our study, wherever
possible, we used glue with lipiodol in high- and intermediate-flow lesions and STS in low-flow
lesions, and we found it a very effective combination.
The majority of patients with PVMs may require multiple sessions. In our study, only five out of
15 patients (33.3%) had a single session. Six out of 15 patients (40%) had two sessions. Three
out of 15 patients (20%) had three sessions and one patient had seven sessions.
The results of our study demonstrated a marked response in 73.34% of patients and a partial
response in 26.67% with a 0% failure rate.Two patients with high-flow malformation underwent
surgery after sclerotherapy with a complete excision of the lesion. With the mean follow-up of
2.71 years, we conclude that sclerotherapy with or without embolization is a safe and effective
treatment modality, with most patients experiencing symptom relief. STS is a safe and effective
treatment modality; however, it needs multiple sessions and long-term follow-up. Special
attention, with effective monitoring, should be done for distal extremity and head and neck
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lesions.
The limitations of our study are that it is a retrospective study with a small sample size.
Conclusions
PVMs are complex lesions. Sclerotherapy, with or without embolization, is a safe and effective
treatment modality with clinical success approaching 100%. Many patients will need multiple
sessions, and long-term follow-up is the key to success.
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